Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
13,271,249
-
Shares change
-
+1,070,722
-
Total reported value, excl. options
-
$742,032,915
-
Value change
-
+$66,544,263
-
Number of buys
-
35
-
Number of sells
-
-26
-
Price
-
$56.15
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q1 2020
70 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q1 2020.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,271,249 shares
of 34,723,329 outstanding shares and own 38% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (3,144,000 shares), Redmile Group, LLC (3,144,000 shares), JANUS HENDERSON GROUP PLC (1,478,805 shares), RA CAPITAL MANAGEMENT, L.P. (982,723 shares), PRICE T ROWE ASSOCIATES INC /MD/ (818,302 shares), VANGUARD GROUP INC (499,879 shares), ALKEON CAPITAL MANAGEMENT LLC (483,600 shares), BlackRock Inc. (446,640 shares), Cormorant Asset Management, LP (426,104 shares), and HILLHOUSE CAPITAL ADVISORS, LTD. (350,000 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.